IL10 and COVID-19: The current study aims to assess the association of COVID-19 severity and mortality with the relative expression of miR-155 and its association with serum levels of the pro-inflammatory cytokine interleukin (IL)−6, the anti-inflammatory cytokine IL-10, and their derived ratio as indicators for the cytokine storm.